Do entities conducting clinical trials definitely need to conclude additional compulsory third-party liability insurance agreements under the recently amended Medical Professions Act?

| Wednesday March 17th, 2021

In our last post on this subject (available at http://ipllectual.pl/pl/nowe-obowiazkowe-ubezpieczenie-udzial-maloletniego-i-przepisy-karne-omowienie-najwazniejszych-zmian-w-przeprowadzaniu-eksperymentow-medycznych/)  we gave an overview of the most important changes to the law on conducting...
read more »

“The only one of its kind on the market, antiviral properties” – advertising medicinal products in the age of the pandemic

| 28/05/2020

The advertising of medicinal products is strictly regulated. During a pandemic, responsible entities should take extra care when producing advertising content. It may turn out that previously...
read more »

Advertising medicines by providing free samples

| 29/01/2020

Due to the extensive selection of medicinal products available on the market, businesses are undertaking a variety of marketing activities in order to reach the widest possible group of patients...
read more »
Tracking IP trends
in Poland and beyond

Categories

Most Popular Tags

trademarks | GDPR | | personal data | copyright | privacy | personal data protection | movie | directive 2016/943 | trade secrets | regulatory compliance | novel food | personal rights | Valentine's Day | obstacles to trademark registration | EFSA | licence fee, royalties | know-how | the "Produkt polski" mark | media społecznościowe

Archives

  • 2021 (8)
  • 2020 (23)
  • 2019 (7)
  • 2018 (46)
  • 2017 (3)
I agree X

We use cookies to enhance the functionality of the website by storing your preferences. By continuing to use this site, you accept these cookies.